Formation of ultrafine deferasirox particles via rapid expansion of supercritical solution (RESS process) using Taguchi approach

International Journal of Pharmaceutics

Volumn 433, Issue 1-2, 2012, Pages 149-156

  Asghari, Iman ^a   Esmaeilzadeh, Feridun ^a  

^a SHIRAZ UNIVERSITY   (Iran)

Author keywords

Deferasirox; Iron chelator; Nanoparticles; RESS process; SC CO2; Taguchi

Indexed keywords

2 PROPANOL; ACETONE; CARBON DIOXIDE; DEFERASIROX;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PRESSURE; PRIORITY JOURNAL; RAPID EXPANSION OF SUPERCRITICAL SOLUTION PROCESS; TEMPERATURE;

BENZOATES; DRUG COMPOUNDING; IRON CHELATING AGENTS; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TRIAZOLES;

EID: 84862897698     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.005     Document Type: Article

References (35)

1. Cox, D.R., Reid, N., 2000. The Theory of the Design of Experiments. Chapman & Hall/CRC.
2. Dasu, V.V., Panda, T., Chidambaram, M., 2003. Determination of significant parameters for improved griseofulvin production in a batch bioreactor by Taguchi's method. Process Biochem. 38, 877-880. (Pubitemid 36189119)
3. Dobbs, J.M., Wong, J.M., Lahiere, R.J., Johnston, K.P., 1987. Modification of supercritical fluid phase behavior using polar cosolvents. Ind. Eng. Chem. Res. 26, 56-65. (Pubitemid 17588604)
4. Dobbs, J.M., Johnston, K.P., 1987. Selectivities in pure and mixed supercritical fluid solvents. Ind. Eng. Chem. Res. 26, 1476-1482.
5. Del Valle, E.M.M., Galan, M.A., 2005. Supercritical fluid technique for particle engineering: drug delivery applications. Rev. Chem. Eng. 21, 33-69. (Pubitemid 40289026)
6. Lipinski, C.A., 2002. Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 5, 82-85.
7. Fages, J., Lochard, H., Letourneau, J.J., Sauceau, M., Rodier, E., 2004. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol. 141, 219-226. (Pubitemid 38726140)
8. Hezave, A.Z., Esmaeilzadeh, F., 2010. Micronization of drug particles via RESS process. J. Supercrit. Fluids 52, 84-98.
9. Huang, Z., Sun, G.B., Chiew, Y.C., Kawi, S., 2005. Formation of ultra fine aspirin particles through rapid expansion of supercritical solutions (RESS). Powder Technol. 160, 127-134. (Pubitemid 41560933)
10. Huang, Z., Lu, W.D., Kawi, S., Chiew, Y.C., 2004. J. Chem. Eng. Data 49, 1323-1327.
11. Hirunsit, P., Huang, Z., Srinophakun, T., Charoenchaitrakool, M., Kawi, S., 2005. Particle formation of ibuprofen supercritical CO2 system from rapid expansion of supercritical solutions (RESS): a mathematical model. Powder Technol. 154, 83-94. (Pubitemid 40957072)
12. Hershko, C., Konijn, A.M., Nick, H.P., Breuer, W., Cabantchik, Z.I., Link, G., 2001. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97, 1115-1122. (Pubitemid 32154301)
13. Jung, J., Perrut, M., 2001. Particle design using supercritical fluids: literature and patent survey. J Supercrit. Fluids 20, 179-219. (Pubitemid 32607129)
14. Kayser, O., Lemke, A., Hernandez-Trejo, N., 2005. The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol. 6, 3-5. (Pubitemid 40246748)
15. Kayrak, D., Akman, U., Hortac su, O., 2003a. Micronization of ibuprofen by RESS. J. Supercrit. Fluids 26, 17-31.
16. Kayrak, D., Akman, U., Hortacsu, O., 2003b. J. Supercrit. Fluids 26, 17.
17. Kröber, H., Teipel, U., Krause, H., 2000. The formation of small organic particles using supercritical fluids. In: Proceedings of the 5th International Symposium on Supercritical Fluids, 8-12 April, Atlanta, USA.
18. Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47-60. (Pubitemid 30326688)
19. Muller, R.H., Jacobs, C., Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47, 3-19. (Pubitemid 32209229)
20. Mainardes, R.M., Silva, L.P., 2004. Drug delivery systems: past, present and future. Curr. Drug Targets 5, 449-455. (Pubitemid 38807819)
21. Nick, H., Acklin, P., Lattmann, R., Buehlmayer, P., Hauffe, S., Schupp, J., Alberti, D., 2003. Development of tridentates iron chelators: from desferrithiocin to ICL670. Curr. Med. Chem. 10, 1065-1076. (Pubitemid 36582249)
22. Noyes, A., Whitney, W., 1897. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 19, 930-934.
23. Nagahama, K., Liu, G.T., 1997. Supercritical fluid crystallization of solid solution. In: The 4th International Symposium on Supercritical Fluids, 11-14 May, Sendai, Japan, pp. 43-46.
24. Peace, G.S., 1993. Taguchi Methods: A Hands-on Approach. Addison-Wesley Publishing Company, Inc., Massachusetts.
25. Piga, A., Gaglioti, C., Fogliacco, E., Tricta, F., 2003. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica 88, 489-496. (Pubitemid 36648438)
26. Rabinow, B.E., 2004. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 3, 785-796. (Pubitemid 39242830)
27. Rehman, M., Shekunov, B.Y., York, P., Colthorpe, P., 2001. J. Pharm. Sci. 90, 1570.
28. Ross, R.J., 1989. Taguchi Techniques for Quality Engineering. McGraw-Hill, New York.
29. Ryan, N.E., 1988. Taguchi Methods and QFD: Hows and Whys for Management. ASI, Press, Michigan.
30. Stanton, L.A., Dehghani, F., Foster, N.R., 2002. Improving drug delivery using polymers and supercritical fluid technology. Aust. J. Chem. 55, 443-447. (Pubitemid 35221084)
31. Thakur, R., Gupta, R.B., 2006a. Rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process: formation of 2-aminobenzoic acid nanoparticle. J. Supercrit. Fluids 37, 307-315. (Pubitemid 44382476)
32. Thakur, R., Gupta, R.B., 2006b. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process. Int. J. Pharm. 308, 190-199. (Pubitemid 43097252)
33. Tom, J.W., Debenedetti, P.G., Jerome, R.J., 1994. J. Supercrit. Fluids 7, 9.
34. Turk, M., Hils, P., Helfgen, B., Schaber, K., Martin, H.J., Wahl, M.A., 2002. J. Supercrit. Fluids 22, 75-84.
35. Yildiz, N., Tuna, S., Doker, O., Calimli, A., 2007. Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS). J. Supercrit. Fluids 41, 440-451. (Pubitemid 46661143)